Cancer
-
From Gene Discovery to a FDA approval; Belzutifan’s Fascinating Journey at UTSW
Published on: August 21, 2021 A novel kidney cancer drug developed from UT Southwestern Medical Center received approval from the Food…
Read More » -
Keytruda plus Lenvima Combo Received FDA Approval for Advanced Kidney Cancer
August 20, 2021 Frontline Keytruda plus Lenvima for advanced renal cell carcinoma is an effective treatment with life-prolonging benefits, although…
Read More » -
Combo of cabozantinib plus atezolizumab active across kidney cancer subtypes
September 9, 2021 By Gregor Kreth Recent findings based on the phase 1b COSMIC-021 trial in Journal of Clinical Oncology…
Read More » -
US FDA Approves Belzutifan for Tumors Associated With Certain Types of Von Hippel-Lindau Disease
By Gregor Kreth, Guest Writer August 16, 2021 FDA approves Merck’s Welireg for the treatment of adult patients with von…
Read More » -
Medical Disclaimer
– The contents of the GUcancers Site, such as text, graphics, images, and other material contained on the GUcancers Site…
Read More » -
TERMS AND CONDITIONS OF USE
PLEASE READ THE FOLLOWING TERMS AND CONDITIONS OF USE (THE “TERMS”) CAREFULLY BEFORE USING THIS WEB SITE (THE “SITE”) AND…
Read More » -
Advertising Policy
GUcancers accepts advertising on the GUcancers Network from third parties (“Advertisers”), which may include third party banners, badges, contextual advertising…
Read More » -
Editorial policy
GUcancers.com and its affiliates (“GUCancers” or “Biomedz” or “we”), which operate www.GUcancers.com (“GUCancers”), are committed to providing GUCancers users with…
Read More » -
ASCO21 Meeting Summary – Kidney Cancer
Practice Changing Results in RCC come from ASCO 2021 Ochsner Precision Cancer Therapies Program and Ochsner Cancer Institute, Benson Cancer…
Read More » -
ASCO21 Sessions: RECOMMENDED ABSTRACTS in Renal Cancer
These recommended abstracts have been selected by Robert A. Figlin, MD, Editor-in- Chief of the Kidney Cancer Journal. The chosen abstracts provided…
Read More »
